Your browser doesn't support javascript.
loading
[Keratomycosis - Therapy Standards and New Developments]. / Keratomykose - Therapiestandards und aktuelle Entwicklungen.
Behrens-Baumann, W; Finis, D; MacKenzie, C; Roth, M; Geerling, G.
Affiliation
  • Behrens-Baumann W; Universitätsaugenklinik, Otto-von-Guericke-Universität Magdeburg.
  • Finis D; Augenklinik, Heinrich-Heine-Universität Düsseldorf.
  • MacKenzie C; Institut für Medizinische Mikrobiologie und Krankenhaushygiene, Heinrich-Heine-Universität Düsseldorf.
  • Roth M; Augenklinik, Heinrich-Heine-Universität Düsseldorf.
  • Geerling G; Augenklinik, Heinrich-Heine-Universität Düsseldorf.
Klin Monbl Augenheilkd ; 232(6): 754-64, 2015 Jun.
Article in De | MEDLINE | ID: mdl-26084964
ABSTRACT
Mycotic keratitis is a comparatively rare but serious ophthalmological disease, that can possibly lead to a severe loss of vision up to blindness. Over the last two decades an increase of cases with mycotic keratitis has been noticed, which is possibly caused by an increased use of soft contact lenses. This article gives an overview of the typical clinical signs and symptoms of keratomycosis, tried and tested diagnostics and therapy as well as new diagnostic and therapeutic developments and findings.
Subject(s)

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Eye Infections, Fungal / Contact Lenses, Hydrophilic / Keratitis / Antifungal Agents Type of study: Guideline Limits: Humans Language: De Journal: Klin Monbl Augenheilkd Year: 2015 Document type: Article

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Eye Infections, Fungal / Contact Lenses, Hydrophilic / Keratitis / Antifungal Agents Type of study: Guideline Limits: Humans Language: De Journal: Klin Monbl Augenheilkd Year: 2015 Document type: Article